HB0356 • 2026

Drug Distribution Amendments

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor: Rep. Monson, Logan
Last action: 2026-02-27
Official status: Governor Signed
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Drug Distribution Amendments

This bill amends provisions related to the 340B drug discount program.

What This Bill Does

This bill amends provisions related to the 340B drug discount program.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2026-02-27 Lieutenant Governor's office for filing
Governor Signed
2026-02-24 Clerk of the House
House/ received enrolled bill from Printing
2026-02-24 Executive Branch - Governor
House/ to Governor
2026-02-20 Legislative Research and General Counsel / Enrolling
Bill Received from House for Enrolling
2026-02-20 Legislative Research and General Counsel / Enrolling
Draft of Enrolled Bill Prepared
2026-02-20 Clerk of the House
Enrolled Bill Returned to House or Senate
2026-02-20 Clerk of the House
House/ enrolled bill to Printing
2026-02-19 House Speaker
House/ received from Senate
2026-02-19 Legislative Research and General Counsel / Enrolling
House/ signed by Speaker/ sent for enrolling
2026-02-19 Senate 3rd Reading Calendar
Senate/ 3rd reading
2026-02-19 Senate President
Senate/ passed 3rd reading
2026-02-19 House Speaker
Senate/ signed by President/ returned to House
2026-02-19 House Speaker
Senate/ to House
2026-02-18 Senate 2nd Reading Calendar
Senate/ 2nd reading
2026-02-18 Senate 3rd Reading Calendar
Senate/ passed 2nd reading
2026-02-17 Senate Health and Human Services Committee
Senate/ committee report favorable
2026-02-17 Senate 2nd Reading Calendar
Senate/ placed on 2nd Reading Calendar
2026-02-12 Senate Health and Human Services Committee
Senate Comm - Favorable Recommendation
2026-02-06 Senate Health and Human Services Committee
Senate/ to standing committee
2026-02-04 House Consent Calendar
House/ 3rd reading
2026-02-04 Senate Secretary
House/ passed 3rd reading
2026-02-04 Senate Secretary
House/ to Senate
2026-02-04 Senate Rules Committee
Senate/ 1st reading (Introduced)
2026-02-04 Waiting for Introduction in the Senate
Senate/ received from House
2026-02-02 House Consent Calendar
House/ 2nd reading
2026-02-02 House Health and Human Services Committee
House/ comm rpt/ placed on Consent Calendar
2026-01-30 House Health and Human Services Committee
House Comm - Consent Calendar Recommendation
2026-01-30 House Health and Human Services Committee
House Comm - Favorable Recommendation
2026-01-30 House Health and Human Services Committee
House/ to standing committee
2026-01-29 House Rules Committee
House/ received fiscal note from Fiscal Analyst
2026-01-29 Released
LFA/ fiscal note publicly available for HB0356
2026-01-29 Version Sponsor
LFA/ fiscal note sent to sponsor for HB0356
2026-01-26 House Rules Committee
House/ 1st reading (Introduced)
2026-01-26 Clerk of the House
House/ received bill from Legislative Research
2026-01-23 Legislative Research and General Counsel
Bill Numbered but not Distributed
2026-01-23 Legislative Fiscal Analyst
LFA/ bill assigned to staff for fiscal analysis for HB0356
2026-01-23 Legislative Fiscal Agency
LFA/ bill sent to agencies for fiscal input for HB0356
2026-01-23 Legislative Research and General Counsel
Numbered Bill Publicly Distributed

Official Summary Text

This bill amends provisions related to the 340B drug discount program.

Current Bill Text

Read the full stored bill text

15
31A-46-311
0
Drug Distribution Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Logan J. Monson
Senate Sponsor: Evan J. Vickers
LONG TITLE
General Description:
This bill amends provisions related to the 340B drug discount program.
Highlighted Provisions:
This bill:
defines a 340B covered entity and a 340B eligible drug;
clarifies prohibited actions under the 340B drug discount program;
defines terms; and
makes technical and conforming changes.
Money Appropriated in this Bill:
None
Other Special Clauses:
This bill provides a special effective date.
Utah Code Sections Affected:
AMENDS:
31A-46-311
, as enacted by Laws of Utah 2025, Chapter 514
Be it enacted by the Legislature of the state of Utah:
Section 1. Section
31A-46-311
is amended to read:
31A-46-311
. Prohibited actions with respect to the 340B drug discount program.
(1)
As used in this section
,
:
(a)
"340B covered entity" means the same as the term "covered entity" is defined in 42
U.S.C. Sec. 256b(a)(4).
(b)
"340B eligible drug" means a drug purchased through the 340B drug discount
program, in accordance with 42 U.S.C. Sec. 256b, by a 340B covered entity.
(c)
"Contracted pharmacy" means a pharmacy contracting with a 340B covered entity to
dispense 340B eligible drugs.
(d)
"manufacturer"
"Manufacturer"
means a pharmaceutical manufacturer, including an
agent or affiliate of a pharmaceutical manufacturer.
(e)
"Pharmacy" means any place where drugs are dispensed.
(2)
A manufacturer may not:
(a)
directly or indirectly restrict or prohibit:
(i)
a pharmacy from contracting with a 340B
covered
entity, including by denying the
pharmacy access to a drug that is manufactured by the manufacturer;
(ii)
a 340B
covered
entity from contracting with a pharmacy, including by denying
the 340B
covered
entity access to a drug that is manufactured by the manufacturer;
(iii)
the acquisition, dispensing, or delivery of a 340B
eligible
drug to any location
authorized by a 340B
covered
entity to receive the drug, unless prohibited by
federal law; or
(iv)
a 340B
covered
entity from receiving
340B drug discount program pricing for
a
340B
eligible
drug, including by imposing a time limitation on a 340B
covered
entity to replenish or submit a claim for a 340B
eligible
drug;
(b)
directly or indirectly:
(i)
require a 340B
covered
entity to purchase a 340B
eligible
drug from a supplier if
the manufacturer would otherwise permit the 340B
covered
entity to purchase a
drug that is not a 340B
eligible
drug from the supplier; or
(ii)
require a 340B
covered
entity
or a contracted pharmacy
to submit any claim data,
utilization data, or information about a 340B
covered
entity's contracts with a
third-party
, unless the data or information sharing is required by federal law,
as a
condition for allowing
:

(A)
the acquisition of a 340B
eligible
drug by
,
a 340B covered entity;
or
(B)
delivery of a 340B
eligible
drug to
,
a 340B
covered
entity
, unless the data
or information sharing is required by federal law
or a contracted pharmacy
; or
(c)
interfere with:
(i)
a contract between a pharmacy and a 340B
covered
entity; or
(ii)
the ability of a pharmacy and a 340B
covered
entity to enter into a contract.
(3)
The Public Employees' Benefit and Insurance Program created in Section
49-20-103

may adjust the program's business practices to mitigate any financial impacts resulting
from this section.
(4)
Nothing in this section is to be construed to conflict with federal law.
Section 2.
Effective Date.
This bill takes effect:
(1)
except as provided in Subsection (2),
May 6, 2026
; or
(2)
if approved by two-thirds of all members elected to each house:
(a)
upon approval by the governor;
(b)
without the governor's signature, the day following the constitutional time limit of
Utah Constitution, Article VII, Section 8; or
(c)
in the case of a veto, the date of veto override.
1-23-26 11:47 AM